These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 23911110)

  • 1. The effectiveness of restarted lithium treatment after discontinuation: reviewing the evidence for discontinuation-induced refractoriness.
    de Vries C; van Bergen A; Regeer EJ; Benthem E; Kupka RW; Boks MP
    Bipolar Disord; 2013 Sep; 15(6):645-9. PubMed ID: 23911110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lithium for bipolar disorder: a review of the recent literature.
    Curran G; Ravindran A
    Expert Rev Neurother; 2014 Sep; 14(9):1079-98. PubMed ID: 25130062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study.
    Severus WE; Kleindienst N; Evoniuk G; Bowden C; Möller HJ; Bohus M; Frangou S; Greil W; Calabrese JR
    J Affect Disord; 2009 Jun; 115(3):466-70. PubMed ID: 19019453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term clinical effectiveness of lithium maintenance treatment in types I and II bipolar disorders.
    Tondo L; Baldessarini RJ; Floris G
    Br J Psychiatry Suppl; 2001 Jun; 41():s184-90. PubMed ID: 11450181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Risk of inducing resistance upon stopping and restarting lithium after long-term usage].
    Oostervink F; Nolen WA; Hoenderboom AC; Kupka RW
    Ned Tijdschr Geneeskd; 2000 Feb; 144(9):401-4. PubMed ID: 10719540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lithium treatment of acute mania in adolescents: a placebo-controlled discontinuation study.
    Kafantaris V; Coletti DJ; Dicker R; Padula G; Pleak RR; Alvir JM
    J Am Acad Child Adolesc Psychiatry; 2004 Aug; 43(8):984-93. PubMed ID: 15266193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuation versus discontinuation of lithium in recurrent bipolar illness: a naturalistic study.
    Biel MG; Peselow E; Mulcare L; Case BG; Fieve R
    Bipolar Disord; 2007 Aug; 9(5):435-42. PubMed ID: 17680913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lithium in the long-term treatment of bipolar disorders.
    Kleindienst N; Greil W
    Eur Arch Psychiatry Clin Neurosci; 2003 Jun; 253(3):120-5. PubMed ID: 12904975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled lithium discontinuation in bipolar patients with good response to long-term lithium prophylaxis.
    Yazici O; Kora K; Polat A; Saylan M
    J Affect Disord; 2004 Jun; 80(2-3):269-71. PubMed ID: 15207941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bouncing back: is the bipolar rebound phenomenon peculiar to lithium? A retrospective naturalistic study.
    Franks M; Macritchie KA; Mahmood T; Young AH
    J Psychopharmacol; 2008 Jun; 22(4):452-6. PubMed ID: 18635725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White matter hyperintensity detected by magnetic resonance imaging and lithium response in bipolar disorder: a preliminary observation.
    Kato T; Fujii K; Kamiya A; Kato N
    Psychiatry Clin Neurosci; 2000 Feb; 54(1):117-20. PubMed ID: 15558889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choline in the treatment of rapid-cycling bipolar disorder: clinical and neurochemical findings in lithium-treated patients.
    Stoll AL; Sachs GS; Cohen BM; Lafer B; Christensen JD; Renshaw PF
    Biol Psychiatry; 1996 Sep; 40(5):382-8. PubMed ID: 8874839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omega-3 fatty acid deficiency augments amphetamine-induced behavioral sensitization in adult mice: prevention by chronic lithium treatment.
    McNamara RK; Sullivan J; Richtand NM
    J Psychiatr Res; 2008 May; 42(6):458-68. PubMed ID: 17628596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effectiveness of lithium in the prophylaxis of affective disorders].
    Ezquiaga E; García-López A; Nieves P; Rodríguez-Salvanés F
    Actas Esp Psiquiatr; 2000; 28(3):156-60. PubMed ID: 11000697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine production in bipolar affective disorder patients under lithium treatment.
    Boufidou F; Nikolaou C; Alevizos B; Liappas IA; Christodoulou GN
    J Affect Disord; 2004 Oct; 82(2):309-13. PubMed ID: 15488263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence in bipolar I disorder: a post hoc analysis excluding relapses in two double-blind maintenance studies.
    Calabrese JR; Goldberg JF; Ketter TA; Suppes T; Frye M; White R; DeVeaugh-Geiss A; Thompson TR
    Biol Psychiatry; 2006 Jun; 59(11):1061-4. PubMed ID: 16769295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Has the time come to abandon prophylactic lithium treatment? A review for clinicians.
    Schou M
    Pharmacopsychiatry; 1998 Nov; 31(6):210-5. PubMed ID: 9930634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does lithium protect against dementia?
    Kessing LV; Forman JL; Andersen PK
    Bipolar Disord; 2010 Feb; 12(1):87-94. PubMed ID: 20148870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recurrence following discontinuation of 28 years of lithium therapy].
    Wegmann SD; Kessing LV
    Ugeskr Laeger; 2011 Mar; 173(11):820-1. PubMed ID: 21402017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lithium: the long road.
    Gershon S; Chengappa KN
    Bipolar Disord; 2010 Nov; 12(7):667-8. PubMed ID: 21040284
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.